Type 2 Diabetes Market By Product, By End User, By Ship Type, By Material, By Application, By Region And Forecast 2023-2032|F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories

The Business Research Company’s Type 2 Diabetes Global Market Report 2024 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Type 2 Diabetes Global Market Report 2023 evaluates type 2 diabetes market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=13050&type=smp

The global type 2 diabetes market is expected to grow from $44.56 billion in 2023 to $48.14 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to lifestyle and dietary changes, aging population, pharmaceutical developments, public health initiatives. The type 2 diabetes market size is expected to see strong growth in the next few years. It will grow to $65.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%.

Increasing rates of obesity and heart disease are expected to propel the growth of the type 2 diabetes market going forward. Obesity is a medical condition where excess body fat has accumulated to an unhealthy level, while heart disease refers to a range of conditions that affect the heart and blood vessels. Excess body weight increases the risk of insulin resistance, leading to high blood sugar levels and the development of type 2 diabetes. In contrast, high blood sugar levels can damage blood vessels and nerves that control the heart and blood vessels, leading to heart disease. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, severe obesity in the US increased from 4.7% to 9.2% in 2021. Furthermore, in March 2022, according to a report published by the Office for National Statistics, a UK-based government department, the number of deaths from heart disease increased from 19,440 in 2020 to 20,061 in 2021. Therefore, rising rates of obesity and heart disease are driving the growth of the type 2 diabetes market.

Get More Information On The Type 2 Diabetes Market Report:

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

The type 2 diabetes market segments in the report are:

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes

2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

3) By End-User: Children, Adults

The table of contents in TBRC’s type 2 diabetes market report includes:

  1. Executive Summary
  2. Type 2 Diabetes Market Characteristics
  3. Type 2 Diabetes Market Trends And Strategies
  4. Type 2 Diabetes Market – Macro Economic Scenario
  5. Global Type 2 Diabetes Market Size and Growth

.

.

.

  1. Type 2 Diabetes Market Other Major And Innovative Companies
  2. Global Type 2 Diabetes Market Competitive Benchmarking
  3. Global Type 2 Diabetes Market Competitive Dashboard
  4. Key Mergers And Acquisitions In The Type 2 Diabetes Market
  5. Type 2 Diabetes Market Future Outlook and Potential Analysis

Top Major Players

  • Hoffmann-La Roche AG
  • Merck and Co. Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Abbott Laboratories

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model